Atorvastatin hemicalcium salt
Product #:
TL0047
Image
SKU-Pack Size
Stock
Price($)
Quantity
-
-
TL0047-250MG
In stock
41.4
-
+
TL0047-1G
In stock
88.6
-
+
Details
l General Information |
Product Name | Atorvastatin hemicalcium salt |
General description | Atorvastatin hemicalcium salt is the calcium salt of atorvastatin, a synthetic lipid-lowering agent. Atorvastatin is a HMG-CoA Reductase Inhibitor. The mechanism of action of atorvastatin is as a Hydroxymethylglutaryl-CoA Reductase Inhibitor. |
Synonym | (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5 dihydroxyheptanoate, hemicalcium salt |
Purity | ≥98%(HPLC) | CAS Number | 134523-03-8 |
Formula | C66H68CaF2N4O10 | Molecular Weight | 1155.363 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Atorvastatin Calcium is the calcium salt of atorvastatin, a synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent increases the number of LDL receptors on hepatic cell surfaces, enhancing the uptake and catabolism of LDL and reducing LDL production and the number of LDL particles, and lowers plasma cholesterol and lipoprotein levels. Like other statins, atorvastatin may also display direct antineoplastic activity, possibly by inhibiting farnesylation and geranylgeranylation of proteins such as small GTP-binding proteins, which may result in the arrest of cells in the G1 phase of the cell cycle. This agent may also sensitize tumor cells to cyctostatic drugs, possibly through the mTOR-dependent inhibition of Akt phosphorylation. |
Application | 1. Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. 2. Anticholesteremic Agents Substances used to lower plasma cholesterol levels. |
l Packaging & Storage |
Packaging | 250mg; 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |